<DOC>
	<DOCNO>NCT01621945</DOCNO>
	<brief_summary>The main objective study estimate proportion child , bear 06/04/2004 17/004/2008 , live around Neufchatel en Bray , vaccinate MenBVac , serum bactericidal activity B:14 , P1-7,16 clone relate protection ( &gt; = 4 ) , fourth dose MenBvac : 6 week one year fourth dose .</brief_summary>
	<brief_title>Evaluation Immune Response Against Strain Neisseria Meningitidis B : 14 , P1-7 , 16 Patients Having Vaccinated MenBVac® ( Extension EFFIVAC )</brief_title>
	<detailed_description />
	<criteria>child bear 06/04/2004 17/04/2008 , live Neufchatel en Bray , Having participate first study , child Have Vaccinated MenBVac® four time , parental authority ( y ) assent . parental authority ( y ) assent , blood sample , impossibility fourth vaccination , child yet vaccinate non eligible vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Neisseria meningitidis B:14 , P1-7 , 16</keyword>
	<keyword>Serum bactericidal activity</keyword>
	<keyword>OMV vaccine</keyword>
</DOC>